This inventor holds 1 USPTO granted patent. Top assignee: Samyang Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations of Hyun Suk Yu in Transdermal Drug Delivery Systems
Introduction
Hyun Suk Yu is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative designs and patents. His work focuses on enhancing the efficacy and convenience of transdermal drug delivery methods.
Latest Patents
One of Hyun Suk Yu's key patents is the "Dual adhesive transdermal drug delivery system." This invention comprises a support layer, a first drug-containing adhesive layer, and a second drug-containing adhesive layer. Each layer has a proximal and distal surface, with the distal surfaces laminated to the support layer. Additionally, a peelable backing layer is positioned over and laminated to the proximal surfaces of the adhesive layers. This innovative design aims to improve the delivery of drugs through the skin, providing a more effective treatment option for patients.
Career Highlights
Hyun Suk Yu is associated with Samyang Corporation, where he continues to develop and refine his inventions. His work at the company has positioned him as a key player in the advancement of pharmaceutical technologies. His dedication to research and development has led to the creation of effective drug delivery systems that benefit both healthcare providers and patients.
Collaborations
Hyun Suk Yu collaborates with talented colleagues, including Young Kweon Choi and Hye Jeong Yoon. These partnerships enhance the innovative process and contribute to the successful development of new technologies in the pharmaceutical field.
Conclusion
Hyun Suk Yu's contributions to transdermal drug delivery systems exemplify the importance of innovation in healthcare. His patented technologies have the potential to significantly improve patient outcomes and advance the field of drug delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
